Navigation Links
A much-needed shot in the arm for HIV vaccine development

International efforts towards developing a vaccine against HIV infection have been given a much-needed boost by the publication today of the Global HIV/AIDS Vaccine Enterprise's scientific strategic plan, published online in the freely available, open-access global health journal PLoS Medicine. The Global HIV/AIDS Vaccine Enterprise is an international alliance of independent agencies and organizations conducting or supporting HIV vaccine research. In June 2004, the G8 countries endorsed its goals, and will consider the new plan at its forthcoming summit meeting in the United Kingdom this July.

The coordinating committee of the plan reads like a "who's who" of global AIDS experts, including Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health; Peter Piot, Executive Director of UNAIDS; and Pascoal Mocumbi, former Prime Minister of Mozambique and Representative of the European Developing Country Clinical Trials Partnership. The Enterprise partners include many of the world's top AIDS vaccine funding and advocacy organizations, including the Bill & Melinda Gates Foundation, the US National Institutes of Health, the International AIDS Vaccine Initiative, the World Health Organization, UNAIDS, and the AIDS Vaccines Advocacy Coalition. The plan, developed with the collaboration of over 140 scientists worldwide, identifies the major scientific roadblocks facing HIV vaccine development, outlines a strategic approach to addressing them, and proposes an innovative collaborative model that ensures that researchers across the globe are harnessing their efforts towards a common goal. "Development of an HIV vaccine remains one of the most difficult challenges confronting biomedical research today," write the plan's authors, but fortunately "scientific progress has created new opportunities that could be harnessed more effectively through global coordination and collaboration." "These new opportunit
'"/>

Source:PLoS Medicine


Page: 1 2 3

Related biology news :

1. Research advances quest for HIV-1 vaccine
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. Gene vaccine for Alzheimers disease shows promising results
4. Influenza vaccine uses insect cells to speed development
5. Norovirus, AIDS vaccine and Hepatitis Virus
6. HIV vaccine trial breaks ground for future research
7. Live vaccines more effective against horse herpes virus
8. NIAID begins clinical trial of West Nile virus vaccine
9. Designing vaccines by computer
10. Wake Forest scientists find new combination vaccine effective against plague
11. New vaccine means bye-bye to bacteria in the lung
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: much needed shot the arm for HIV vaccine development

(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... oceanographers including a researcher from Scripps Institution of Oceanography ... of tropical oceans are expanding as the oceans warm, ... marine organisms can live or enter in search of ... Stramma from the Leibniz Institute of Marine Sciences (IFM-GEOMAR) ...
... potential of biochar, or charcoal made from biological tissues (e.g., ... in the soil. This is because charcoal is carbon-rich and ... years. This has led to the suggestion being seriously considered ... large quantities and stored in soils. This would in turn ...
... University of Florida researchers have identified a drug ... and in a remarkable finding prevents damage ... hypertension. The findings, which appear in todays (May ... could lead to a new class of antihypertensive drugs ...
Cached Biology News:Oxygen depletion: A new form of ocean habitat loss 2Limitations of charcoal as an effective carbon sink 2UF scientists discover compound that could lead to new blood pressure drugs 2UF scientists discover compound that could lead to new blood pressure drugs 3
(Date:12/15/2014)... PETACH TIKVAH, Israel , Dec. 15, ... BCLI ), a leading developer of adult stem cell ... Brainstorm Cell Therapeutics Ltd. was awarded a grant of ... Office of the Chief Scientist (OCS).  This is the ... grant support from the Office of the Chief Scientist, ...
(Date:12/15/2014)... -- GlassesOff Inc. (OTCBB: GLSO) announced today the appointment of ... of the Company,s Board of Directors. Mr. ... CEO until its acquisition by Stanley Black ... as the inventor of the first Wi-Fi-based Active RFID ... RFID solutions focused on improving operational efficiency, safety and ...
(Date:12/15/2014)... , Dec. 15, 2014  Ascendis Pharma A/S, ... technology to address significant unmet medical needs, today ... Phase 2 pediatric study to evaluate once-weekly TransCon ... or GHD.  This interim analysis consists of 25 ... enrollment in the study, completing all six months ...
(Date:12/13/2014)... /CNW/ - MaRS and Virgin Unite Canada, the non-profit foundation ... forces to support Canadian entrepreneurs tackling social and environmental challenges. ... at the MaRS Centre to announce the new partnership, which ... This fund has $1 million in seed capital provided by ... Mindset Social Innovation Foundation, founded by Alison Lawton . ...
Breaking Biology Technology:BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
... July 7 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ... executive officer (CEO), has announced his,intent to retire on ... to serve on the Board. Mr. Freiman is the ... California., Mr. Freiman is retiring after 11 years ...
... Pharmaceuticals,Inc. ("Angiotech") (NASDAQ: ANPI , TSX: ANP), ... announced the commencement,of a cash tender offer of ... amount that will result in an aggregate purchase ... Tender Premiums" listed in the,table below) of $165 ...
... and PHILADELPHIA, July 4 ,Shire Limited (LSE:SHP, NASDAQ: SHPGY), ... earnings on,Thursday 31 July 2008, Results press ... BST / 07:00 EDT Investor meeting and conference ... Investor & Analyst meeting and conference call:, Angus ...
Cached Biology Technology:Neurobiological Technologies' CEO to Retire on December 31, 2008 2Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 2Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 3Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 4Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 5Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 6Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 7Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014 8Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008 2
... for western blots ,• Optically clear plastic ... staining western blots. The reduced size (60 ... disposable tray requires less dye and antibodies ... the user. Pour spouts in each corner ...
... pLivSelect is a ... for recombinant identification. Recombinant ... colony survival, eliminating the ... screening. This quick and ...
... Qentix Western Blot Signal Enhancer does for enzyme-/substrate-based ... it increases the signal up to 10-fold ... minutes., ,The Western Blot Signal Enhancer membrane ... be added to your current Western blotting ...
... Solid phase extraction through columns is ... range of applications. Typical applications are in ... in diagnostics, or compound purification in chemical ... fully automated on the Genesis series instruments ...
Biology Products: